Stay updated on Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page adds a recruitment-status note ('No longer looking for participants') and introduces new help/navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also standardizes the 'Intervention/Treatment' heading and updates the site revision to v3.6.0, replacing v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-14T04:58:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces the prior Revision: v3.5.4 on the study page, signaling a new edition of the page content with likely minor updates.
    Difference
    0.1%
    Check dated 2026-06-07T00:21:06.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed. This reflects a minor page version update without altering the study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-05-16T09:57:25.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/software version change rather than any change to the trial information displayed.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:34.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:51:21.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added AA amyloidosis and multiple myeloma as related disease terms and included the Genetic and Rare Diseases Information Center as a resource.
    Difference
    0.2%
    Check dated 2026-04-03T05:47:06.000Z thumbnail image

Stay in the know with updates to Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Post-Transplant in Multiple Myeloma Clinical Trial page.